These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10087185)

  • 21. The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.
    Kroll M; Conconi M; Desterro MJ; Marin A; Thomas D; Friguet B; Hay RT; Virelizier JL; Arenzana-Seisdedos F; Rodriguez MS
    Oncogene; 1997 Oct; 15(15):1841-50. PubMed ID: 9362451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A switch in distinct I kappa B alpha degradation mechanisms mediates constitutive NF-kappa B activation in mature B cells.
    Fields ER; Seufzer BJ; Oltz EM; Miyamoto S
    J Immunol; 2000 May; 164(9):4762-7. PubMed ID: 10779782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome.
    Kroll M; Arenzana-Seisdedos F; Bachelerie F; Thomas D; Friguet B; Conconi M
    Chem Biol; 1999 Oct; 6(10):689-98. PubMed ID: 10508680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha.
    Dai RM; Chen E; Longo DL; Gorbea CM; Li CC
    J Biol Chem; 1998 Feb; 273(6):3562-73. PubMed ID: 9452483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide-induced NF-kappaB activation in human endothelial cells involves degradation of IkappaBalpha but not IkappaBbeta.
    Zen K; Karsan A; Eunson T; Yee E; Harlan JM
    Exp Cell Res; 1998 Sep; 243(2):425-33. PubMed ID: 9743602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control.
    Marienfeld R; Berberich-Siebelt F; Berberich I; Denk A; Serfling E; Neumann M
    Oncogene; 2001 Dec; 20(56):8142-7. PubMed ID: 11781828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression.
    Natarajan K; Manna SK; Chaturvedi MM; Aggarwal BB
    Arch Biochem Biophys; 1998 Apr; 352(1):59-70. PubMed ID: 9521814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
    Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
    Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome.
    Sahali D; Pawlak A; Gouvello SL; Lang P; Valanciuté A; Remy P; Loirat C; Niaudet P; Bensman A; Guellaen G
    J Am Soc Nephrol; 2001 Aug; 12(8):1648-1658. PubMed ID: 11461937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
    Li CC; Dai RM; Longo DL
    Biochem Biophys Res Commun; 1995 Oct; 215(1):292-301. PubMed ID: 7575604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to IkappaBalpha phosphorylated by IKK, leading to ubiquitination.
    Suzuki H; Chiba T; Kobayashi M; Takeuchi M; Furuichi K; Tanaka K
    Biochem Biophys Res Commun; 1999 Mar; 256(1):121-6. PubMed ID: 10066434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation.
    Yamin TT; Miller DK
    J Biol Chem; 1997 Aug; 272(34):21540-7. PubMed ID: 9261174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low intracellular zinc impairs the translocation of activated NF-kappa B to the nuclei in human neuroblastoma IMR-32 cells.
    Mackenzie GG; Zago MP; Keen CL; Oteiza PI
    J Biol Chem; 2002 Sep; 277(37):34610-7. PubMed ID: 12089148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compensatory increase in USP14 activity accompanies impaired proteasomal proteolysis during aging.
    Ponnappan S; Palmieri M; Sullivan DH; Ponnappan U
    Mech Ageing Dev; 2013; 134(1-2):53-9. PubMed ID: 23291607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for lowered induction of nuclear factor kappa B in activated human T lymphocytes during aging.
    Trebilcock GU; Ponnappan U
    Gerontology; 1996; 42(3):137-46. PubMed ID: 8796372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caretaker or undertaker? The role of the proteasome in aging.
    Gaczynska M; Osmulski PA; Ward WF
    Mech Ageing Dev; 2001 Mar; 122(3):235-54. PubMed ID: 11311314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constitutive degradation of IkappaBalpha in human T lymphocytes is mediated by calpain.
    Ponnappan S; Cullen SJ; Ponnappan U
    Immun Ageing; 2005 Nov; 2():15. PubMed ID: 16271147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis.
    Finco TS; Baldwin AS
    Immunity; 1995 Sep; 3(3):263-72. PubMed ID: 7552992
    [No Abstract]   [Full Text] [Related]  

  • 39. Less degradation, more shock, please.
    Bush KT; Nigam SK
    Gastroenterology; 1999 Apr; 116(4):994-5. PubMed ID: 10092324
    [No Abstract]   [Full Text] [Related]  

  • 40. Age-related alterations of proteasome structure and function in aging epidermis.
    Bulteau AL; Petropoulos I; Friguet B
    Exp Gerontol; 2000 Sep; 35(6-7):767-77. PubMed ID: 11053667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.